0001104659-23-102823.txt : 20230921 0001104659-23-102823.hdr.sgml : 20230921 20230921161517 ACCESSION NUMBER: 0001104659-23-102823 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230919 FILED AS OF DATE: 20230921 DATE AS OF CHANGE: 20230921 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Groman Dan CENTRAL INDEX KEY: 0001881296 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40949 FILM NUMBER: 231269269 MAIL ADDRESS: STREET 1: C/O ENFUSION INC. STREET 2: 125 SOUTH CLARK STREET STE. 750 CITY: CHICAGO STATE: IL ZIP: 60603 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Enfusion, Inc. CENTRAL INDEX KEY: 0001868912 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-PREPACKAGED SOFTWARE [7372] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 125 SOUTH CLARK STREET, SUITE 750 CITY: CHICAGO STATE: IL ZIP: 60603 BUSINESS PHONE: (312) 253-9800 MAIL ADDRESS: STREET 1: 125 SOUTH CLARK STREET, SUITE 750 CITY: CHICAGO STATE: IL ZIP: 60603 4 1 tm2326639-1_4seq1.xml OWNERSHIP DOCUMENT X0508 4 2023-09-19 0 0001868912 Enfusion, Inc. ENFN 0001881296 Groman Dan C/O ENFUSION, INC. 125 SOUTH CLARK STREET SUITE 750 CHICAGO IL 60603 0 1 0 0 Chief Technology Officer 1 Class A Common Stock 2023-09-19 4 S 0 5000 9.07 D 143828 D The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on June 15, 2023. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $9.00 to $9.12. Full information regarding the number of shares sold at each separate price will be furnished to the SEC staff upon request. /s/ Matthew Campobasso, as Attorney-in-Fact 2023-09-21